fda warning bpc-157 compounding mulls for peptides previously flagged over safety risks fda warning bpc-157 compounded peptide

Thymosin Beta-4 could heal ligament injuries A rat study involving the local administration of Thymosin Beta-4 discovered that Thymosin Beta-4 has potential clinical use in repairing ligaments [14]

Safety and efficacy in pediatric populations have not been established

Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, et al

In biochemical and cellular research models, BPC-157 has been reported to interact with multiple signalling pathways, including nitric oxideassociated mechanisms, growth factor-related signalling, and cytoskeletal regulatory processes

Contact us today to schedule your consultation and find out if vitamin B12 injections may be right for you